Role of primary care physician in care for patients with chronic obstructive pulmonary disease

Background. COPD causes significant damage to the health of the population, is characterized by a high rate of morbidity and mortality. Late presentation, when persistent changes in bronchopulmonary tissue have already been formed, is associated with a limitation of the treatment efficacyand an increase in medical expenses. In addition, the true prevalence of COPD is distorted, and the low percentage of person’s identification with COPD risk factors development limits preventive measures aimed to timely and rational pulmonological care to patients.

Objective. To study the COPD morbidity, to assess its structure and preventive measures, as well as COPD mortality among the adult population of Lipetsk.

Materials and methods. 9900 patients aged 18 and over were examined, taken under follow-up care in Lipetsk adult polyclinic N 4. There were preparation of the study protocol, screening by computer database "Register of patients with COPD", formation of a clinical examination group, analysis of statistical data of Public health department of Lipetsk Region and indicators of follow-up care of certain groups of the adult population at Lipetsk adult polyclinic N 4 in the study.

Results. COPD is a common disease among residents of Lipetsk, developing in both men and women, with smoking being the leading risk factor for the disease development. The preventive measures taken are insufficient. Thedetection of COPD by medical aid appealability prevails, and the detected COPD were moderate and extremely severe course, and according to group B and D (GOLD, 2022).

Conclusion. To reduce the COPD prevalence, risk factors, disease progression, exacerbations frequency, clinical symptoms control, stable course, and as a result, improve COPD prognosis and reduce COPD mortality, it is advisably to continue to improve the quality of preventive measures, improve early COPD diagnosis at the primary care stage, detect and prevent complications of the disease in a timely manner.

1. Bystritskaya E. V., Bilichenko T. N. Themorbidity, disability, and mortality associated with respiratory diseases in the Russian Federation (2015-2019). Pul’monologiya. 2021; 31 (5): 551-561. DOI: 10.18093/0869-0189-2021-31-5-551-561. (In Russ.)

2. Drapkina O. M., Kontsevaya A. V., Mukaneeva D. K., et al. Forecast of the socioeconomic burden of COPD in the Russian Federation in 2022. Pulmonologiya. 2022; 32 (4): 507-516. https://doi.org/10.18093/0869-0189-2022-32-4-507-516. (In Russ.)

3. Clinical guidelines of the Ministry of Health of the Russian Federation "Chronic Obstructive Pulmonary Disease" (update 2021). https://cr.minzdrav.gov.ru/recomend/603_2. (In Russ.)

4. Soriano J. B., Polverino F., Cosio B. G. Hat is early COPD and why is it important? Eur Respir J. 2018; 52 (6): 801448. DOI: 10.1183/13993003.01448-2018.

5. Sandelowsky H., Weinreich U. M., Aarli B. B., et al. COPD – do the right thing. BMC Fam Pract. 2021; 22 (1): 244. DOI: 10.1186/s12875-021-01583-w.

6. Order of the Ministry of Health of the Russian Federation No. 404n dated 27.04.2021 "On approval of the Procedure for preventive medical examination and follow-up careof certain groups of the adult population". (In Russ.)

7. Prozorova G. G., Burlachuk V. T., Tribuntceva L. V., et al. Improvement of dispensary observation of patients with COPD based on the patient-specific phenotype approach. Nauchno-meditsinskii vestnik Centralnogo Chernozemya. 2018; 74: 66-70. (In Russ.)

8. Orlova E. A., Dorfman I. P., Orlov M. A., et al. Contemporary issues in vaccine prophylaxis ofchronic obstructive pulmonary disease in modern clinical practice conditions. Astraxanskii meditsinskii zhurnal. 2020; 15 (1): 84-98. (In Russ.)

9. Drapkina O. M., Kontsevaya A. V., Kalinina A. M., et al. 2022 prevention of chronic non-communicable diseases in the Russian Federation. National Guidelines. Cardiovascular Therapy and Prevention. 2022; 21 (4): 5-232. (In Russ.)

10. Global strategy for prevention, diagnosis and management of COPD (Global Initiative for Obstructive Lung Disease, GOLD 2022). https://goldcopd.org/2022-gold-reports/